Anteris Technologies Global/$AVR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Anteris Technologies Global
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
Ticker
$AVR
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Toowong, Australia
Employees
136
ISIN
US03675P1021
Website
AVR Metrics
BasicAdvanced
$151M
-
-$3.30
0.29
-
Price and volume
Market cap
$151M
Beta
0.29
52-week high
$8.36
52-week low
$2.34
Average daily volume
198K
Financial strength
Current ratio
3.673
Quick ratio
3.516
Long term debt to equity
1.311
Total debt to equity
4.685
Interest coverage (TTM)
-158.09%
Management effectiveness
Return on equity (TTM)
-263.65%
Valuation
Price to revenue (TTM)
42.151
Price to book
5.42
Price to tangible book (TTM)
5.44
Price to free cash flow (TTM)
-1.553
Growth
Revenue change (TTM)
-8.85%
Earnings per share change (TTM)
2.56%
3-year revenue growth (CAGR)
-18.73%
3-year earnings per share growth (CAGR)
18.16%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Anteris Technologies Global stock?
Anteris Technologies Global (AVR) has a market cap of $151M as of May 31, 2025.
What is the P/E ratio for Anteris Technologies Global stock?
The price to earnings (P/E) ratio for Anteris Technologies Global (AVR) stock is 0 as of May 31, 2025.
Does Anteris Technologies Global stock pay dividends?
No, Anteris Technologies Global (AVR) stock does not pay dividends to its shareholders as of May 31, 2025.
When is the next Anteris Technologies Global dividend payment date?
Anteris Technologies Global (AVR) stock does not pay dividends to its shareholders.
What is the beta indicator for Anteris Technologies Global?
Anteris Technologies Global (AVR) has a beta rating of 0.29. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.